Opus Genetics, Inc. (IRD) stock news · rev $14.2M
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
This IRD news page leads with what Opus Genetics, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for IRD yet. We will not pad this page with generic market recap.
Latest reported IRD revenue for 2025-12-31 was $14.2M. Net income was -$49.6M. Revenue was up 29.1% from 2024-12-31 to 2025-12-31. IRD currently screens at market cap $35.7M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IRD stock page; for the tape open the quote page.
IRD stock news FAQ
What are IRD's latest revenue and net income?
Latest cached Opus Genetics, Inc. (IRD) revenue for Dec 31, 2025 was $14.2M. Net income was -$49.6M. Statements: https://lician.com/financials/ird
How did IRD revenue change from the prior cached period?
Cached Opus Genetics, Inc. (IRD) revenue was up 29.1% from $11.0M (Dec 31, 2024) to $14.2M (Dec 31, 2025). Statements: https://lician.com/financials/ird
What is IRD's market cap?
Opus Genetics, Inc. (IRD) market cap is $35.7M on the latest cached fundamentals snapshot.
What kind of company is IRD?
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Where is IRD stock news listed?
Cached stock news for Opus Genetics, Inc. (IRD) is listed at https://lician.com/news/ird. Filings: https://lician.com/sec/ird
Not investment advice.